143 related articles for article (PubMed ID: 15863889)
1. Inhibition of tyrosinase activity by N,N-unsubstituted selenourea derivatives.
Ha SK; Koketsu M; Lee K; Choi SY; Park JH; Ishihara H; Kim SY
Biol Pharm Bull; 2005 May; 28(5):838-40. PubMed ID: 15863889
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of 1,3-selenazol-4-one derivatives on mushroom tyrosinase.
Koketsu M; Choi SY; Ishihara H; Lim BO; Kim H; Kim SY
Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1594-6. PubMed ID: 12499597
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibitory effects of N-aryl S-alkylthiocarbamate derivatives on the dopa oxidase activity of mushroom tyrosinase.
Lee KH; Koketsu M; Choi SY; Lee KJ; Lee P; Ishihara H; Kim SY
Chem Pharm Bull (Tokyo); 2005 Jul; 53(7):747-9. PubMed ID: 15997128
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of thiazolidinone derivatives as a new class of mushroom tyrosinase inhibitors.
Rezaei M; Mohammadi HT; Mahdavi A; Shourian M; Ghafouri H
Int J Biol Macromol; 2018 Mar; 108():205-213. PubMed ID: 29180052
[TBL] [Abstract][Full Text] [Related]
5. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase.
Shin NH; Ryu SY; Choi EJ; Kang SH; Chang IM; Min KR; Kim Y
Biochem Biophys Res Commun; 1998 Feb; 243(3):801-3. PubMed ID: 9500997
[TBL] [Abstract][Full Text] [Related]
6. Effect of p-aminophenols on tyrosinase activity.
Komori Y; Imai M; Yamauchi T; Higashiyama K; Takahashi N
Bioorg Med Chem; 2014 Aug; 22(15):3994-4000. PubMed ID: 24972725
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of novel pyrimidine derivatives as a new class of mushroom tyrosinase inhibitor.
Mirmortazavi SS; Farvandi M; Ghafouri H; Mohammadi A; Shourian M
Drug Des Devel Ther; 2019; 13():2169-2178. PubMed ID: 31371919
[TBL] [Abstract][Full Text] [Related]
8. Regulation of melanin synthesis by selenium-containing carbohydrates.
Ahn SJ; Koketsu M; Ishihara H; Lee SM; Ha SK; Lee KH; Kang TH; Kima SY
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):281-6. PubMed ID: 16508177
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and tyrosinase inhibitory properties of novel isoquinoline urea/thiourea derivatives.
Genç H; Zengin M; Yavuz E; Gençer N; Arslan O
Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):178-85. PubMed ID: 23590347
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of ergothioneine inhibition of mushroom tyrosinase.
Liao WC; Wu WH; Tsai PC; Wang HF; Liu YH; Chan CF
Appl Biochem Biotechnol; 2012 Jan; 166(2):259-67. PubMed ID: 22068690
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
Saeed A; Mahesar PA; Channar PA; Abbas Q; Larik FA; Hassan M; Raza H; Seo SY
Bioorg Chem; 2017 Oct; 74():187-196. PubMed ID: 28837887
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.
Ashraf Z; Rafiq M; Seo SY; Babar MM; Zaidi NU
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):874-83. PubMed ID: 25643758
[TBL] [Abstract][Full Text] [Related]
13. N-(3,5-dihydroxybenzoyl)-6-hydroxytryptamine as a novel human tyrosinase inhibitor that inactivates the enzyme in cooperation with l-3,4-dihydroxyphenylalanine.
Yamazaki Y; Kawano Y
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1536-40. PubMed ID: 21048351
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
[TBL] [Abstract][Full Text] [Related]
15. Searching for indole derivatives as potential mushroom tyrosinase inhibitors.
Ferro S; Certo G; De Luca L; Germanò MP; Rapisarda A; Gitto R
J Enzyme Inhib Med Chem; 2016; 31(3):398-403. PubMed ID: 25826148
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of thiourea derivatives with sulfur-containing heterocyclic scaffolds as potential tyrosinase inhibitors.
Liu P; Shu C; Liu L; Huang Q; Peng Y
Bioorg Med Chem; 2016 Apr; 24(8):1866-71. PubMed ID: 26972919
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel hydroxybenzaldehyde-based kojic acid analogues as inhibitors of mushroom tyrosinase.
Xie W; Zhang H; He J; Zhang J; Yu Q; Luo C; Li S
Bioorg Med Chem Lett; 2017 Feb; 27(3):530-532. PubMed ID: 28011217
[TBL] [Abstract][Full Text] [Related]
18. Novel synthetic kojic acid-methimazole derivatives inhibit mushroom tyrosinase and melanogenesis.
Chen MJ; Hung CC; Chen YR; Lai ST; Chan CF
J Biosci Bioeng; 2016 Dec; 122(6):666-672. PubMed ID: 27353860
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of novel synthetic methimazole derivatives on mushroom tyrosinase and melanogenesis.
Chan CF; Lai ST; Guo YC; Chen MJ
Bioorg Med Chem; 2014 May; 22(9):2809-15. PubMed ID: 24703463
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
